We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recombinant thrombin approved.
- Authors
Ratner, Mark
- Abstract
The article reports on the giving of approval for Recothrom to be used in controlling the bleeding during surgery by the U.S. marketing in January 17. According to the author, Recothrom is the first recombinant thrombin and will compete with a bovine thrombin product sold by Bristol. He added that after watching King increase its pricing and grow its Thrombin-JMI franchise to $200 million annually, Zymogenetics has decided to enter the thrombin market. Moreover, Piper Jaffray analyst Edward Tenthoff has stated that Thrombin stops bleeding whether it's a cow or a person.
- Subjects
UNITED States; OPERATIVE surgery; HEMORRHAGE prevention; BLOOD coagulation factors; THROMBIN; PRICING; RETAIL franchises; TENTHOFF, Edward; PIPER Jaffray &; Co.
- Publication
Nature Biotechnology, 2008, Vol 26, Issue 3, p250
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0308-250